Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: A randomized controlled trial

JAMA

Volumn 285, Issue 10, 2001, Pages 1299-1307

  Sackeim, Harold A ^a,b   Haskett, Roger F ^c   Mulsant, Benoit H ^c   Thase, Michael E ^c   Mann, J John ^a,b   Pettinati, Helen M ^d,f   Greenberg, Robert M ^d,g   Crowe, Raymond R ^e   Cooper, Thomas B ^a,b   Prudic, Joan ^a,b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b University of Pittsburgh ^*  (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d Carrier Foundation   (United States)

^e UNIVERSITY OF IOWA   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g St Francis Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM CARBONATE; MONOAMINE OXIDASE INHIBITOR; NORTRIPTYLINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ANOREXIA; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFICACY; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTENSION; INSOMNIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; RELAPSE; STEADY STATE; SYNCOPE; VERTIGO; VOMITING; XEROSTOMIA;

EID: 0035857786     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.285.10.1299     Document Type: Article

References (76)

1. Use of ECT in the United States in 1975, 1980, and 1986
2. Electroconvulsive therapy
3. Continuation therapy following ECT: Directions for future research
4. The clinical use of electroconvulsive therapy in old age
5. Delusional depression and electroconvulsive therapy: One year later
6. Continuation therapy after ECT for delusional depression: A naturalistic study of prophylactic treatments and relapse
7. The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression
8. Antidepressant drug treatment in relation to the use of ECT
9. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy
10. Shortened REM latency post-ECT is associated with rapid recurrence of depressive symptomatology
11. Temporary results only in electroconvulsive therapy in therapy-resistant depression: Retrospective study
12. Seven-year prognosis in depression: Mortality and readmission risk in the Nottingham ECT cohort
13. Two-year outcome of psychotic depression in late life
14. A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities
15. Imipramine with electrical treatment in depression: A controlled trial
16. The influence of antidepressant drugs on the response to electroconvulsive therapy and on subsequent relapse rates
17. A seven-month double-blind trial of amitriptyline and diazepam in ECT-treated depressed patients
18. Relapse prevention by means of paroxetine in ECT-treated patients with major depression: A comparison with imipramine and placebo in medium-term continuation therapy
19. Continuation therapy with antidepressants after electroconvulsive therapy
20. Treatment of medication-resistant depression with electroconvulsive therapy
21. Clinical trial of the treatment of depressive illness: Report to the Medical Research Council by its Clinical Psychiatry Committee
22. The effect of sequential antidepressant treatment on geriatric depression
23. Citalopram: Clinical effect profile in comparison with clomipramine: A controlled multicenter study
24. The efficacy of selective serotonin reuptake inhibitors in depression: A meta-analysis of studies against tricyclic antidepressants
25. Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia
26. Characteristics of responders to fluoxetine
27. Paroxetine in the treatment of melancholia and severe depression
28. Paroxetine: A selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study
29. Resistance to antidepressant medications and short-term clinical response to ECT
30. Lithium carbonate addition in tricylic antidepressant-resistant unipolar depression
31. A comparison of electroconvulsive therapy with a combined lithium and tricydic combination among depressed tricyclic nonresponders
32. Comparison of 2 treatment strategies for depressed inpatients: Imipramine and lithium addition or mirtazapine and lithium addition
33. Lithium carbonate augmentation of antidepressant treatment: An effective prescription for treatment-refractory depression
34. A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression
35. The benefit of lithium carbonate adjunct in refractory depression: Fact or fiction?
36. Treatment of imipramine-resistant recurrent depression, II: An open clinical trial of lithium augmentation
37. Low use of neuroleptic drugs in the treatment of psychotic major depression
38. A diagnostic interview: The Schedule for Affective Disorders and Schizophrenia
39. Research diagnostic criteria: Rationale and reliability
40. Development of a rating scale for primary depressive illness
41. Continuation drug therapy for major depressive episodes: How long should it be maintained?
42. Long-term treatment of mood disorders
43. Unilateral electroconvulsive therapy
44. Seizure threshold in electroconvulsive therapy: Effects of sex, age, electrode placement, and number of treatments
45. Medication resistance and clinical response to electroconvulsive therapy
46. Prediction of individual dosage of nortriptyline
47. The 24-hour lithium level as a prognosticator of dosage requirements: A 2-year follow-up study
48. Issues related to the prediction of optimum dosage
49. Rating chronic medical illness burden in geropsychiatric practice and research: Application of the Cumulative Illness Rating Scale (CIRS)
50. Asymptomatically efficient rank invariant procedure
51. Titrated moderately suprathreshold vs fixed high-dose right unilateral electroconvulsive therapy: Acute antidepressant and cognitive effects
52. A prospective study of lithium continuation therapy in depressed patients who have responded to electroconvulsive therapy
53. The effect of treatment on the two-year course of late-life depression
54. Steering Committee of the American Psychiatric Association The Expert Consensus Guideline Series treatment of bipolar disorder
55. American Psychiatric Association Practice guideline for the treatment of patients with bipolar disorder
56. Lithium continuation therapy following electroconvulsive therapy
57. How long should drug therapy for depression be maintained?
58. Factors associated with 1 -year outcome of major depression in the community
59. The prediction of recovery using a multivariate model in 1471 depressed in patients
60. The Zurich Study, XII: Sex differences in depression: Evidence from longitudinal epidemiological data
61. Sex and depression in the National Comorbidity Survey, I: Lifetime prevalence, chronicity and recurrence
62. First-episode major depression: Few sex differences in course
63. ECT response in depressed patients with and without a DSM-III personality disorder
64. The impact of clinically diagnosed personality disorders on acute and one-year outcomes of electroconvulsive therapy
65. Initiation and adaptation a paradigm for understanding psychotropic drug action
66. Risk of recurrence following discontinuation of lithium treatment in bipolar disorder
67. Effects of the rate of discontinuing lithium maintenance treatment in bipolar disorders
68. High relapse rate after discontinuation of adjunctive medication for elderly patients with recurrent major depression